# EbolaIntel

> Independent Ebola outbreak intelligence: strain-by-strain compatibility for every approved vaccine and treatment, citation-heavy outbreak history, plain-language explainers. Operated from Münster, Germany.

EbolaIntel was built as a public-service editorial reference during the 17 May 2026 WHO PHEIC for Bundibugyo virus in the Democratic Republic of the Congo and Uganda. The single most consequential claim on the site, repeated across every relevant page and sourced to FDA + EMA labels, is this: no approved Ebola vaccine or therapeutic targets Bundibugyo virus. All four approved Ebola products (Ervebo, Zabdeno + Mvabea, Inmazeb, Ebanga) cover Zaire ebolavirus only.

The site has no tracking, no consent banners, no third-party analytics. All data is released under CC BY 4.0.

## Active outbreak

- [Active 2026 PHEIC briefing](https://ebolaintel.com/outbreak/2026-drc-uganda): the canonical reference page for the active outbreak, with cases, deaths, geography, response context, and source links
- [Interactive outbreak map](https://ebolaintel.com/map): MapLibre + OpenFreeMap, every recorded outbreak since 1976
- [News timeline](https://ebolaintel.com/news): curated coverage from WHO, Africa CDC, STAT, Reuters, AP, Science, Imperial College
- [Update log](https://ebolaintel.com/changes): every material edit to outbreak data, dated and explained

## Strain reference

- [All strains index](https://ebolaintel.com/strains): the six recognised ebolavirus species
- [Bundibugyo virus (BDBV)](https://ebolaintel.com/strains/bundibugyo): the strain behind the 2026 PHEIC
- [Zaire ebolavirus (EBOV)](https://ebolaintel.com/strains/zaire): the most lethal and best-studied species
- [Sudan virus (SUDV)](https://ebolaintel.com/strains/sudan): second most common cause of recognised outbreaks

## Vaccines and therapeutics

- [Approved Ebola vaccines](https://ebolaintel.com/vaccines): Ervebo, Zabdeno + Mvabea (both Zaire-strain only)
- [Approved Ebola therapeutics](https://ebolaintel.com/treatments): Inmazeb, Ebanga (both Zaire-strain only)
- [Investigational candidates](https://ebolaintel.com/vaccines/investigational): SUDV and BDBV candidates in development

## Clinical reference

- [Symptoms + differential diagnosis](https://ebolaintel.com/symptoms): dry- and wet-phase presentation, overlap with malaria, typhoid, Lassa, Marburg, dengue
- [Travel guidance](https://ebolaintel.com/travel): risk profiles for tourists, healthcare workers, miners
- [Outbreak history since 1976](https://ebolaintel.com/history): every recognised event
- [Comparator: 2026 vs 2014 vs 2018-2020](https://ebolaintel.com/compare): side-by-side strain, scale, geography, response context

## Open data + embeds

- [API documentation](https://ebolaintel.com/api): all endpoints, license, examples
- [outbreaks.json](https://ebolaintel.com/api/v1/outbreaks.json): every recorded outbreak as JSON
- [current outbreak](https://ebolaintel.com/api/v1/outbreak/current.json): live counts for the active PHEIC
- [strains.json](https://ebolaintel.com/api/v1/strains.json): all six species, CFR ranges, vaccine coverage
- [snapshots](https://ebolaintel.com/api/v1/snapshots/current.json): time-series of cases + deaths for the 2026 PHEIC
- [Embed widgets](https://ebolaintel.com/embed): drop-in iframes for newsrooms and dashboards
- [RSS feeds](https://ebolaintel.com/rss.xml) and [news RSS](https://ebolaintel.com/news/rss.xml)

## About + editorial policy

- [About + editorial policy](https://ebolaintel.com/about): operator identity, funding, conflicts of interest
- [Methodology](https://ebolaintel.com/methodology): how we cross-check claims and what counts as a primary source
- [Source ledger](https://ebolaintel.com/sources): every recurring primary source, with cadence and tags
- [FAQ](https://ebolaintel.com/faq): plain answers to the highest-volume Ebola questions in May 2026
- [Impressum (DE)](https://ebolaintel.com/impressum) and [Datenschutz (DE)](https://ebolaintel.com/datenschutz)

## Languages

- [Français](https://ebolaintel.com/fr/): épidémie active, vaccins, souches (subset of pages)

## Operator

- Thomas Kraaibeek, Münster, Germany
- thomas@ebolaintel.com
- Sister projects: Hantaflow (hantavirus signals), FilingIQ (SEC market intelligence)